化合物RG 13022 T3545
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 136831-48-6 | ¥1,560.00 | 询底价 |
1 mL | 136831-48-6 | ¥485.00 | 询底价 |
5 mg | 136831-48-6 | ¥463.00 | 询底价 |
50 mg | 136831-48-6 | ¥2,420.00 | 询底价 |
10 mg | 136831-48-6 | ¥663.00 | 询底价 |
100 mg | 136831-48-6 | ¥3,590.00 | 询底价 |
2 mg | 136831-48-6 | ¥328.00 | 询底价 |
Product Introduction
Bioactivity
英文名: RG13022
描述: RG13022 (Tyrphostin RG13022) 是一种酪氨酸激酶抑制剂,抑制EGF 受体自身磷酸化的IC50值为4 μM。
细胞实验: 40 mM stock solutions of RG13022 is made in 100% DMSO and diluted with the culture medium before addition to the cells. MH-85 cells and HER 14 cells are plated in culture medium in the presence or absence of increasing concentrations of RG-13022 or RG-14620 for 10 days. At the end of culture, the cells are fixed with 4% (v/v) formaldehyde and stained with hematoxylin. Numbers of colonies including more than 20 cells in each well are counted under the microscope[1].
体外活性: RG13022 suppresses EGF-stimulated cancer cell proliferation. In a cell-free reaction, RG13022 inhibits the autophosphorylation reaction of the EGF receptor in immunoprecipitates (IC50: 4 μM). RG13022 inhibits colony formation (IC50: 1 μM) and DNA synthesis (IC50: 3 μM) by HER 14 cells (stimulated by 50 ng/mL EGF), in a dose-dependent manner. RG-13022 inhibits not only EGF-induced growth but also growth stimulated by insulin, insulin-like growth factor I, insulin-like growth factor II, or transforming growth factor alpha. RG-13022 also totally blocks estrogen-stimulated phosphorylation of the EGF receptor, as well as estrogen-induced cell proliferation, suggesting that functioning TK pathways are required for estrogen action.
体内活性: RG13022抑制裸鼠中的肿瘤生长,并延长了这些携带肿瘤裸鼠的寿命。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (187.76 mM)
关键字: HER1 | Inhibitor | RG13022 | EGFR | Tyrphostin RG-13022 | inhibit | ErbB-1 | Tyrphostin RG 13022 | RG-13022 | Epidermal growth factor receptor
相关产品: Erlotinib | WS3 | Neratinib | Nezutatug | PP2 | NRC-2694 | CGP52411 | Lifirafenib | Oritinib | (S)-Sunvozertinib
相关库: Angiogenesis related Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Anti-Ovarian Cancer Compound Library | Inhibitor Library | Kinase Inhibitor Library | Tyrosine Kinase Inhibitor Library | Anti-Cancer Active Compound Library | Anti-Pancreatic Cancer Compound Library | Covalent Inhibitor Library
化合物RG 13022 T3545信息由TargetMol中国为您提供,如您想了解更多关于化合物RG 13022 T3545报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途